Adding Immunotherapy to Neoadjuvant Chemoradiation May Improve Outcomes in Esophageal Cancer
Combination of radiation, chemotherapy, and immunotherapy can shrink tumors and allow surgery, with much better survival rate rather than...
Combination of radiation, chemotherapy, and immunotherapy can shrink tumors and allow surgery, with much better survival rate rather than...
Insights may help uncover mechanisms and management strategies for human cancers PHILADELPHIA – Cancer prevalence rates varied widely across...
PHILADELPHIA – The frequency of second primary malignancies (SPMs) arising in cancer survivors following treatment with CAR T-cell therapy...
Patients who would not have otherwise been candidates for surgery achieved successful resection PHILADELPHIA – Patients with liver cancer...
Study highlights potential benefits of broadening eligibility criteria for clinical trials PHILADELPHIA – Patients with treatment-refractory cancers who received...
Transgender or gender non-conforming cancer survivors had higher odds of most conditions compared to cisgender cancer survivors PHILADELPHIA –...
PHILADELPHIA – The MEK inhibitor trametinib (Mekinist) was an effective treatment for pediatric patients with relapsed or refractory juvenile...
HPV testing eight years after a negative result instead of the recommended five was found comparable to standard cytology...
Among patients over 65 who received an allogeneic hematopoietic stem cell transplant (allo-HCT) for the treatment of acute myeloid...
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the appointment of Nickolas Papadopoulos, PhD, as editor-in-chief...